[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global 3PL Healthcare Logistics Market Insights, Forecast to 2029

November 2023 | 110 pages | ID: G74B4097294FEN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for 3PL Healthcare Logistics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of 3PL Healthcare Logistics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for 3PL Healthcare Logistics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the 3PL Healthcare Logistics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global 3PL Healthcare Logistics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for 3PL Healthcare Logistics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including DHL Supply Chain & Global Forwarding, Kuehne + Nagel, Nippon Express, DB Schenker Logistics, C.H. Robinson Worldwide, DSV Panalpina, Sinotrans, XPO Logistics and UPS Supply Chain Solutions, etc.

By Company
  • DHL Supply Chain & Global Forwarding
  • Kuehne + Nagel
  • Nippon Express
  • DB Schenker Logistics
  • C.H. Robinson Worldwide
  • DSV Panalpina
  • Sinotrans
  • XPO Logistics
  • UPS Supply Chain Solutions
  • J.B. Hunt (JBI, DCS & ICS)
  • Expeditors International of Washington
  • CEVA Logistics
  • Hitachi Transport System
  • Dachser
  • GEODIS
  • Toll Group
Segment by Type
  • Transportation
  • Warehousing
  • Value Added Services
Segment by Application
  • Pharmaceutical Manufacturers
  • Pharmaceutical Distributors
  • Hospital
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East, Africa, and Latin America
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of 3PL Healthcare Logistics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 3PL Healthcare Logistics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 3PL Healthcare Logistics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions
1 ONCOLOGY APOPTOSIS MODULATOR MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Apoptosis Modulator
1.2 Oncology Apoptosis Modulator Segment By Apoptotic Pathway
  1.2.1 Global Oncology Apoptosis Modulator Market Value Comparison By Apoptotic Pathway (2023-2029)
  1.2.2 Extrinsic Pathway
  1.2.3 Intrinsic Pathway
1.3 Oncology Apoptosis Modulator Segment by Application
  1.3.1 Global Oncology Apoptosis Modulator Market Value by Application: (2023-2029)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Oncology Apoptosis Modulator Market Size Estimates and Forecasts
  1.4.1 Global Oncology Apoptosis Modulator Revenue 2018-2029
  1.4.2 Global Oncology Apoptosis Modulator Sales 2018-2029
  1.4.3 Global Oncology Apoptosis Modulator Market Average Price (2018-2029)
1.5 Assumptions and Limitations

2 ONCOLOGY APOPTOSIS MODULATOR MARKET COMPETITION BY MANUFACTURERS

2.1 Global Oncology Apoptosis Modulator Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oncology Apoptosis Modulator Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oncology Apoptosis Modulator Average Price by Manufacturers (2018-2023)
2.4 Global Oncology Apoptosis Modulator Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oncology Apoptosis Modulator, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Apoptosis Modulator, Product Type & Application
2.7 Oncology Apoptosis Modulator Market Competitive Situation and Trends
  2.7.1 Oncology Apoptosis Modulator Market Concentration Rate
  2.7.2 The Global Top 5 and Top 10 Largest Oncology Apoptosis Modulator Players Market Share by Revenue
  2.7.3 Global Oncology Apoptosis Modulator Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 ONCOLOGY APOPTOSIS MODULATOR RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Oncology Apoptosis Modulator Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oncology Apoptosis Modulator Global Oncology Apoptosis Modulator Sales by Region: 2018-2029
  3.2.1 Global Oncology Apoptosis Modulator Sales by Region: 2018-2023
  3.2.2 Global Oncology Apoptosis Modulator Sales by Region: 2024-2029
3.3 Global Oncology Apoptosis Modulator Global Oncology Apoptosis Modulator Revenue by Region: 2018-2029
  3.3.1 Global Oncology Apoptosis Modulator Revenue by Region: 2018-2023
  3.3.2 Global Oncology Apoptosis Modulator Revenue by Region: 2024-2029
3.4 North America Oncology Apoptosis Modulator Market Facts & Figures by Country
  3.4.1 North America Oncology Apoptosis Modulator Market Size by Country: 2018 VS 2022 VS 2029
  3.4.2 North America Oncology Apoptosis Modulator Sales by Country (2018-2029)
  3.4.3 North America Oncology Apoptosis Modulator Revenue by Country (2018-2029)
  3.4.4 United States
  3.4.5 Canada
3.5 Europe Oncology Apoptosis Modulator Market Facts & Figures by Country
  3.5.1 Europe Oncology Apoptosis Modulator Market Size by Country: 2018 VS 2022 VS 2029
  3.5.2 Europe Oncology Apoptosis Modulator Sales by Country (2018-2029)
  3.5.3 Europe Oncology Apoptosis Modulator Revenue by Country (2018-2029)
  3.5.4 Germany
  3.5.5 France
  3.5.6 U.K.
  3.5.7 Italy
  3.5.8 Russia
3.6 Asia Pacific Oncology Apoptosis Modulator Market Facts & Figures by Country
  3.6.1 Asia Pacific Oncology Apoptosis Modulator Market Size by Country: 2018 VS 2022 VS 2029
  3.6.2 Asia Pacific Oncology Apoptosis Modulator Sales by Country (2018-2029)
  3.6.3 Asia Pacific Oncology Apoptosis Modulator Revenue by Country (2018-2029)
  3.6.4 China
  3.6.5 Japan
  3.6.6 South Korea
  3.6.7 India
  3.6.8 Australia
  3.6.9 China Taiwan
  3.6.10 Southeast Asia
3.7 Latin America Oncology Apoptosis Modulator Market Facts & Figures by Country
  3.7.1 Latin America Oncology Apoptosis Modulator Market Size by Country: 2018 VS 2022 VS 2029
  3.7.2 Latin America Oncology Apoptosis Modulator Sales by Country (2018-2029)
  3.7.3 Latin America Oncology Apoptosis Modulator Revenue by Country (2018-2029)
  3.7.4 Mexico
  3.7.5 Brazil
  3.7.6 Argentina
  3.7.7 Colombia
3.8 Middle East and Africa Oncology Apoptosis Modulator Market Facts & Figures by Country
  3.8.1 Middle East and Africa Oncology Apoptosis Modulator Market Size by Country: 2018 VS 2022 VS 2029
  3.8.2 Middle East and Africa Oncology Apoptosis Modulator Sales by Country (2018-2029)
  3.8.3 Middle East and Africa Oncology Apoptosis Modulator Revenue by Country (2018-2029)
  3.8.4 Turkey
  3.8.5 Saudi Arabia
  3.8.6 UAE

4 SEGMENT BY APOPTOTIC PATHWAY

4.1 Global Oncology Apoptosis Modulator Sales By Apoptotic Pathway (2018-2029)
  4.1.1 Global Oncology Apoptosis Modulator Sales By Apoptotic Pathway (2018-2023)
  4.1.2 Global Oncology Apoptosis Modulator Sales By Apoptotic Pathway (2024-2029)
  4.1.3 Global Oncology Apoptosis Modulator Sales Market Share By Apoptotic Pathway (2018-2029)
4.2 Global Oncology Apoptosis Modulator Revenue By Apoptotic Pathway (2018-2029)
  4.2.1 Global Oncology Apoptosis Modulator Revenue By Apoptotic Pathway (2018-2023)
  4.2.2 Global Oncology Apoptosis Modulator Revenue By Apoptotic Pathway (2024-2029)
  4.2.3 Global Oncology Apoptosis Modulator Revenue Market Share By Apoptotic Pathway (2018-2029)
4.3 Global Oncology Apoptosis Modulator Price By Apoptotic Pathway (2018-2029)

5 SEGMENT BY APPLICATION

5.1 Global Oncology Apoptosis Modulator Sales by Application (2018-2029)
  5.1.1 Global Oncology Apoptosis Modulator Sales by Application (2018-2023)
  5.1.2 Global Oncology Apoptosis Modulator Sales by Application (2024-2029)
  5.1.3 Global Oncology Apoptosis Modulator Sales Market Share by Application (2018-2029)
5.2 Global Oncology Apoptosis Modulator Revenue by Application (2018-2029)
  5.2.1 Global Oncology Apoptosis Modulator Revenue by Application (2018-2023)
  5.2.2 Global Oncology Apoptosis Modulator Revenue by Application (2024-2029)
  5.2.3 Global Oncology Apoptosis Modulator Revenue Market Share by Application (2018-2029)
5.3 Global Oncology Apoptosis Modulator Price by Application (2018-2029)

6 KEY COMPANIES PROFILED

6.1 EpiCept Corporation
  6.1.1 EpiCept Corporation Corporation Information
  6.1.2 EpiCept Corporation Description and Business Overview
  6.1.3 EpiCept Corporation Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.1.4 EpiCept Corporation Oncology Apoptosis Modulator Product Portfolio
  6.1.5 EpiCept Corporation Recent Developments/Updates
6.2 Novartis Ltd.
  6.2.1 Novartis Ltd. Corporation Information
  6.2.2 Novartis Ltd. Description and Business Overview
  6.2.3 Novartis Ltd. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.2.4 Novartis Ltd. Oncology Apoptosis Modulator Product Portfolio
  6.2.5 Novartis Ltd. Recent Developments/Updates
6.3 Pfizer Inc.
  6.3.1 Pfizer Inc. Corporation Information
  6.3.2 Pfizer Inc. Description and Business Overview
  6.3.3 Pfizer Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.3.4 Pfizer Inc. Oncology Apoptosis Modulator Product Portfolio
  6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Pharmacyclics, Inc.
  6.4.1 Pharmacyclics, Inc. Corporation Information
  6.4.2 Pharmacyclics, Inc. Description and Business Overview
  6.4.3 Pharmacyclics, Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.4.4 Pharmacyclics, Inc. Oncology Apoptosis Modulator Product Portfolio
  6.4.5 Pharmacyclics, Inc. Recent Developments/Updates
6.5 ISIS Pharmaceutical Inc.
  6.5.1 ISIS Pharmaceutical Inc. Corporation Information
  6.5.2 ISIS Pharmaceutical Inc. Description and Business Overview
  6.5.3 ISIS Pharmaceutical Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.5.4 ISIS Pharmaceutical Inc. Oncology Apoptosis Modulator Product Portfolio
  6.5.5 ISIS Pharmaceutical Inc. Recent Developments/Updates
6.6 Abbott Laboratories
  6.6.1 Abbott Laboratories Corporation Information
  6.6.2 Abbott Laboratories Description and Business Overview
  6.6.3 Abbott Laboratories Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.6.4 Abbott Laboratories Oncology Apoptosis Modulator Product Portfolio
  6.6.5 Abbott Laboratories Recent Developments/Updates
6.7 Genta Inc.
  6.6.1 Genta Inc. Corporation Information
  6.6.2 Genta Inc. Description and Business Overview
  6.6.3 Genta Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.4.4 Genta Inc. Oncology Apoptosis Modulator Product Portfolio
  6.7.5 Genta Inc. Recent Developments/Updates
6.8 Amgen Inc.
  6.8.1 Amgen Inc. Corporation Information
  6.8.2 Amgen Inc. Description and Business Overview
  6.8.3 Amgen Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.8.4 Amgen Inc. Oncology Apoptosis Modulator Product Portfolio
  6.8.5 Amgen Inc. Recent Developments/Updates
6.9 Anavex Life Sciences Corporation
  6.9.1 Anavex Life Sciences Corporation Corporation Information
  6.9.2 Anavex Life Sciences Corporation Description and Business Overview
  6.9.3 Anavex Life Sciences Corporation Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.9.4 Anavex Life Sciences Corporation Oncology Apoptosis Modulator Product Portfolio
  6.9.5 Anavex Life Sciences Corporation Recent Developments/Updates
6.10 Infinity Pharmaceuticals Inc.
  6.10.1 Infinity Pharmaceuticals Inc. Corporation Information
  6.10.2 Infinity Pharmaceuticals Inc. Description and Business Overview
  6.10.3 Infinity Pharmaceuticals Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.10.4 Infinity Pharmaceuticals Inc. Oncology Apoptosis Modulator Product Portfolio
  6.10.5 Infinity Pharmaceuticals Inc. Recent Developments/Updates
6.11 ArQule Inc.
  6.11.1 ArQule Inc. Corporation Information
  6.11.2 ArQule Inc. Oncology Apoptosis Modulator Description and Business Overview
  6.11.3 ArQule Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.11.4 ArQule Inc. Oncology Apoptosis Modulator Product Portfolio
  6.11.5 ArQule Inc. Recent Developments/Updates
6.12 EntreMed Inc.
  6.12.1 EntreMed Inc. Corporation Information
  6.12.2 EntreMed Inc. Oncology Apoptosis Modulator Description and Business Overview
  6.12.3 EntreMed Inc. Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.12.4 EntreMed Inc. Oncology Apoptosis Modulator Product Portfolio
  6.12.5 EntreMed Inc. Recent Developments/Updates
6.13 Theraptosis SA
  6.13.1 Theraptosis SA Corporation Information
  6.13.2 Theraptosis SA Oncology Apoptosis Modulator Description and Business Overview
  6.13.3 Theraptosis SA Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.13.4 Theraptosis SA Oncology Apoptosis Modulator Product Portfolio
  6.13.5 Theraptosis SA Recent Developments/Updates
6.14 ApopLogic Pharmaceuticals Inc
  6.14.1 ApopLogic Pharmaceuticals Inc Corporation Information
  6.14.2 ApopLogic Pharmaceuticals Inc Oncology Apoptosis Modulator Description and Business Overview
  6.14.3 ApopLogic Pharmaceuticals Inc Oncology Apoptosis Modulator Sales, Revenue and Gross Margin (2018-2023)
  6.14.4 ApopLogic Pharmaceuticals Inc Oncology Apoptosis Modulator Product Portfolio
  6.14.5 ApopLogic Pharmaceuticals Inc Recent Developments/Updates

7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

7.1 Oncology Apoptosis Modulator Industry Chain Analysis
7.2 Oncology Apoptosis Modulator Key Raw Materials
  7.2.1 Key Raw Materials
  7.2.2 Raw Materials Key Suppliers
7.3 Oncology Apoptosis Modulator Production Mode & Process
7.4 Oncology Apoptosis Modulator Sales and Marketing
  7.4.1 Oncology Apoptosis Modulator Sales Channels
  7.4.2 Oncology Apoptosis Modulator Distributors
7.5 Oncology Apoptosis Modulator Customers

8 ONCOLOGY APOPTOSIS MODULATOR MARKET DYNAMICS

8.1 Oncology Apoptosis Modulator Industry Trends
8.2 Oncology Apoptosis Modulator Market Drivers
8.3 Oncology Apoptosis Modulator Market Challenges
8.4 Oncology Apoptosis Modulator Market Restraints

9 RESEARCH FINDING AND CONCLUSION


10 METHODOLOGY AND DATA SOURCE

10.1 Methodology/Research Approach
  10.1.1 Research Programs/Design
  10.1.2 Market Size Estimation
  10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
  10.2.1 Secondary Sources
  10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

LIST OF TABLES

Table 1. Global 3PL Healthcare Logistics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Transportation
Table 3. Key Players of Warehousing
Table 4. Key Players of Value Added Services
Table 5. Global 3PL Healthcare Logistics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global 3PL Healthcare Logistics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global 3PL Healthcare Logistics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global 3PL Healthcare Logistics Market Share by Region (2018-2023)
Table 9. Global 3PL Healthcare Logistics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global 3PL Healthcare Logistics Market Share by Region (2024-2029)
Table 11. 3PL Healthcare Logistics Market Trends
Table 12. 3PL Healthcare Logistics Market Drivers
Table 13. 3PL Healthcare Logistics Market Challenges
Table 14. 3PL Healthcare Logistics Market Restraints
Table 15. Global 3PL Healthcare Logistics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global 3PL Healthcare Logistics Revenue Share by Players (2018-2023)
Table 17. Global Top 3PL Healthcare Logistics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3PL Healthcare Logistics as of 2022)
Table 18. Global 3PL Healthcare Logistics Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by 3PL Healthcare Logistics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of 3PL Healthcare Logistics, Headquarters and Area Served
Table 21. Global Key Players of 3PL Healthcare Logistics, Product and Application
Table 22. Global Key Players of 3PL Healthcare Logistics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global 3PL Healthcare Logistics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global 3PL Healthcare Logistics Revenue Market Share by Type (2018-2023)
Table 26. Global 3PL Healthcare Logistics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global 3PL Healthcare Logistics Revenue Market Share by Type (2024-2029)
Table 28. Global 3PL Healthcare Logistics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global 3PL Healthcare Logistics Revenue Share by Application (2018-2023)
Table 30. Global 3PL Healthcare Logistics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global 3PL Healthcare Logistics Revenue Share by Application (2024-2029)
Table 32. North America 3PL Healthcare Logistics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America 3PL Healthcare Logistics Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America 3PL Healthcare Logistics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America 3PL Healthcare Logistics Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America 3PL Healthcare Logistics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America 3PL Healthcare Logistics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America 3PL Healthcare Logistics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe 3PL Healthcare Logistics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe 3PL Healthcare Logistics Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe 3PL Healthcare Logistics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe 3PL Healthcare Logistics Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe 3PL Healthcare Logistics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe 3PL Healthcare Logistics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe 3PL Healthcare Logistics Market Size by Country (2024-2029) & (US$ Million)
Table 46. China 3PL Healthcare Logistics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China 3PL Healthcare Logistics Market Size by Type (2024-2029) & (US$ Million)
Table 48. China 3PL Healthcare Logistics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China 3PL Healthcare Logistics Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia 3PL Healthcare Logistics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia 3PL Healthcare Logistics Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia 3PL Healthcare Logistics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia 3PL Healthcare Logistics Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia 3PL Healthcare Logistics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia 3PL Healthcare Logistics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia 3PL Healthcare Logistics Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America 3PL Healthcare Logistics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size by Country (2024-2029) & (US$ Million)
Table 64. DHL Supply Chain & Global Forwarding Company Details
Table 65. DHL Supply Chain & Global Forwarding Business Overview
Table 66. DHL Supply Chain & Global Forwarding 3PL Healthcare Logistics Product
Table 67. DHL Supply Chain & Global Forwarding Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 68. DHL Supply Chain & Global Forwarding Recent Developments
Table 69. Kuehne + Nagel Company Details
Table 70. Kuehne + Nagel Business Overview
Table 71. Kuehne + Nagel 3PL Healthcare Logistics Product
Table 72. Kuehne + Nagel Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 73. Kuehne + Nagel Recent Developments
Table 74. Nippon Express Company Details
Table 75. Nippon Express Business Overview
Table 76. Nippon Express 3PL Healthcare Logistics Product
Table 77. Nippon Express Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 78. Nippon Express Recent Developments
Table 79. DB Schenker Logistics Company Details
Table 80. DB Schenker Logistics Business Overview
Table 81. DB Schenker Logistics 3PL Healthcare Logistics Product
Table 82. DB Schenker Logistics Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 83. DB Schenker Logistics Recent Developments
Table 84. C.H. Robinson Worldwide Company Details
Table 85. C.H. Robinson Worldwide Business Overview
Table 86. C.H. Robinson Worldwide 3PL Healthcare Logistics Product
Table 87. C.H. Robinson Worldwide Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 88. C.H. Robinson Worldwide Recent Developments
Table 89. DSV Panalpina Company Details
Table 90. DSV Panalpina Business Overview
Table 91. DSV Panalpina 3PL Healthcare Logistics Product
Table 92. DSV Panalpina Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 93. DSV Panalpina Recent Developments
Table 94. Sinotrans Company Details
Table 95. Sinotrans Business Overview
Table 96. Sinotrans 3PL Healthcare Logistics Product
Table 97. Sinotrans Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 98. Sinotrans Recent Developments
Table 99. XPO Logistics Company Details
Table 100. XPO Logistics Business Overview
Table 101. XPO Logistics 3PL Healthcare Logistics Product
Table 102. XPO Logistics Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 103. XPO Logistics Recent Developments
Table 104. UPS Supply Chain Solutions Company Details
Table 105. UPS Supply Chain Solutions Business Overview
Table 106. UPS Supply Chain Solutions 3PL Healthcare Logistics Product
Table 107. UPS Supply Chain Solutions Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 108. UPS Supply Chain Solutions Recent Developments
Table 109. J.B. Hunt (JBI, DCS & ICS) Company Details
Table 110. J.B. Hunt (JBI, DCS & ICS) Business Overview
Table 111. J.B. Hunt (JBI, DCS & ICS) 3PL Healthcare Logistics Product
Table 112. J.B. Hunt (JBI, DCS & ICS) Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 113. J.B. Hunt (JBI, DCS & ICS) Recent Developments
Table 114. Expeditors International of Washington Company Details
Table 115. Expeditors International of Washington Business Overview
Table 116. Expeditors International of Washington 3PL Healthcare Logistics Product
Table 117. Expeditors International of Washington Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 118. Expeditors International of Washington Recent Developments
Table 119. CEVA Logistics Company Details
Table 120. CEVA Logistics Business Overview
Table 121. CEVA Logistics 3PL Healthcare Logistics Product
Table 122. CEVA Logistics Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 123. CEVA Logistics Recent Developments
Table 124. Hitachi Transport System Company Details
Table 125. Hitachi Transport System Business Overview
Table 126. Hitachi Transport System 3PL Healthcare Logistics Product
Table 127. Hitachi Transport System Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 128. Hitachi Transport System Recent Developments
Table 129. Dachser Company Details
Table 130. Dachser Business Overview
Table 131. Dachser 3PL Healthcare Logistics Product
Table 132. Dachser Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 133. Dachser Recent Developments
Table 134. GEODIS Company Details
Table 135. GEODIS Business Overview
Table 136. GEODIS 3PL Healthcare Logistics Product
Table 137. GEODIS Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 138. GEODIS Recent Developments
Table 139. Toll Group Company Details
Table 140. Toll Group Business Overview
Table 141. Toll Group 3PL Healthcare Logistics Product
Table 142. Toll Group Revenue in 3PL Healthcare Logistics Business (2018-2023) & (US$ Million)
Table 143. Toll Group Recent Developments
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global 3PL Healthcare Logistics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global 3PL Healthcare Logistics Market Share by Type: 2022 VS 2029
Figure 3. Transportation Features
Figure 4. Warehousing Features
Figure 5. Value Added Services Features
Figure 6. Global 3PL Healthcare Logistics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global 3PL Healthcare Logistics Market Share by Application: 2022 VS 2029
Figure 8. Pharmaceutical Manufacturers Case Studies
Figure 9. Pharmaceutical Distributors Case Studies
Figure 10. Hospital Case Studies
Figure 11. 3PL Healthcare Logistics Report Years Considered
Figure 12. Global 3PL Healthcare Logistics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global 3PL Healthcare Logistics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global 3PL Healthcare Logistics Market Share by Region: 2022 VS 2029
Figure 15. Global 3PL Healthcare Logistics Market Share by Players in 2022
Figure 16. Global Top 3PL Healthcare Logistics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3PL Healthcare Logistics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by 3PL Healthcare Logistics Revenue in 2022
Figure 18. North America 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America 3PL Healthcare Logistics Market Share by Type (2018-2029)
Figure 20. North America 3PL Healthcare Logistics Market Share by Application (2018-2029)
Figure 21. North America 3PL Healthcare Logistics Market Share by Country (2018-2029)
Figure 22. United States 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe 3PL Healthcare Logistics Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe 3PL Healthcare Logistics Market Share by Type (2018-2029)
Figure 26. Europe 3PL Healthcare Logistics Market Share by Application (2018-2029)
Figure 27. Europe 3PL Healthcare Logistics Market Share by Country (2018-2029)
Figure 28. Germany 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China 3PL Healthcare Logistics Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China 3PL Healthcare Logistics Market Share by Type (2018-2029)
Figure 36. China 3PL Healthcare Logistics Market Share by Application (2018-2029)
Figure 37. Asia 3PL Healthcare Logistics Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia 3PL Healthcare Logistics Market Share by Type (2018-2029)
Figure 39. Asia 3PL Healthcare Logistics Market Share by Application (2018-2029)
Figure 40. Asia 3PL Healthcare Logistics Market Share by Region (2018-2029)
Figure 41. Japan 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America 3PL Healthcare Logistics Market Share by Country (2018-2029)
Figure 51. Brazil 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries 3PL Healthcare Logistics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. DHL Supply Chain & Global Forwarding Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 58. Kuehne + Nagel Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 59. Nippon Express Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 60. DB Schenker Logistics Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 61. C.H. Robinson Worldwide Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 62. DSV Panalpina Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 63. Sinotrans Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 64. XPO Logistics Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 65. UPS Supply Chain Solutions Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 66. J.B. Hunt (JBI, DCS & ICS) Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 67. Expeditors International of Washington Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 68. CEVA Logistics Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 69. Hitachi Transport System Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 70. Dachser Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 71. GEODIS Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 72. Toll Group Revenue Growth Rate in 3PL Healthcare Logistics Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed


More Publications